We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Can secukinumab improve liver fibrosis? A pilot prospective study of 10 psoriatic patients.
- Authors
Magdaleno‐Tapial, Jorge; López‐Martí, Cristina; Ortiz‐Salvador, José María; Hernández‐Bel, Pablo; Tamarit‐García, Juan José; Diago‐Madrid, Moisés; Sánchez‐Carazo, José Luis; Pérez‐Ferriols, Amparo
- Abstract
Despite the small sample size and the absence of a control group, these results suggest that long-term treatment with this drug may reduce the risk of liver fibrosis in our patients. The Fibroscan value improved in all patients, including the two patients who started lipid-lowering treatment, while they maintained similar mean values of weight, body mass index (BMI), and analytical parameters. Can secukinumab improve liver fibrosis?.
- Subjects
FATTY liver; FIBROSIS; WAIST-hip ratio; LIVER histology; NON-alcoholic fatty liver disease; LIVER; LONGITUDINAL method; HIGH density lipoproteins
- Publication
Dermatologic Therapy, 2021, Vol 34, Issue 5, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.15065